Clinical Trials Directory

Trials / Completed

CompletedNCT02976883

[18F]HX4 PET/CT Imaging for Detection of Hypoxia

A Phase II, Single Centre Exploratory Study of [18F]HX4 PET/CT Imaging to Detect Hypoxia in Patients With Head and Neck and Lung Cancer, Receiving Radiotherapy With Curative Intent

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Nottingham University Hospitals NHS Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate the radiotracer \[18F\]HX4 for non-invasive detection of hypoxia in patients with head and neck, or lung cancer. Each participant will undergo a diagnostic \[18F\]HX4 PET/CT scan before beginning radiotherapy treatment. Patient follow up data will be collected from routine appointments, and analysed with the hypoxia scan results to assess whether \[18F\]HX4 PET/CT scanning can predict patient outcome from radiotherapy treatment.

Conditions

Interventions

TypeNameDescription
OTHER[18F]HX4 diagnostic PET/CT scanSingle intravenous injection of \[18F\]HX4 and PET/CT scan

Timeline

Start date
2015-03-31
Primary completion
2017-07-25
Completion
2017-07-25
First posted
2016-11-29
Last updated
2019-01-11

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02976883. Inclusion in this directory is not an endorsement.